FindTrial
Sign In

Study on the influencing factors of blood hypercoagulability in patients after laparoscopic hepatic hemangioma resection

Study on the influencing factors of blood hypercoagulability in patients after laparoscopic hepatic hemangioma resection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054265
Enrollment
Unknown
Registered
2021-12-12
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic hemangioma

Interventions

Non-high coagulation group:None
High coagulation group:None

Sponsors

Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. All patients meet the indications and contraindications of laparoscopic hepatic hemangioma resection; 2. Patients without serious diseases of other organs; 3. The patients gave informed consent and signed the informed consent form for laparoscopic hepatic hemangioma resection, and provided detailed information of the patients.

Exclusion criteria

Exclusion criteria: 1. Patients with liver cancer; 2. Patients with hematological diseases and abnormal coagulation function; 3. Patients with missing or incomplete follow-up data; 4. The patient has taken anticoagulant drugs within one week before surgery.

Design outcomes

Primary

MeasureTime frame
fibrinogen;D-dimer;fibrinogen degradation products ;platelets;low-density lipoprotein cholesterol;high-density lipoprotein cholesterol;history of hyperlipidemia;—

Countries

China

Contacts

Public ContactFu Wen'guang

Affiliated Hospital of Southwest Medical University

fuwg@swmu.edu.cn+86 13982770568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026